MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • 2017 International Congress

    Redefining social work for Parkinson’s: the development of a model of care for specialized support in the clinic, community and home

    A. Lemen, LCSW, M. Sweeney, LMSW, V. Luce, LCSW, D. Rayment, LMSW, A. Di Rocco (New York, NY, USA)

    Objective: The development of a dynamic, multimodal social work program model for individuals, caregivers and families living with Parkinson’s disease Background: Patients living with Parkinson’s…
  • 2016 International Congress

    Impact of the combined depletion of monoamines on the effectiveness of deep brain stimulation of the subthalamic nucleus

    A. Benazzouz, C. Delaville, E. Faggiani (Bordeaux, France)

    Objective: To investigate the involvement of combined depletions of dopamine, norepinephrine and serotonin in the manifestation of motor and non-motor deficits and their impact on…
  • 2016 International Congress

    Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease

    M. Picillo, G. Santangelo, R. Erro, A. Cozzolino, M. Amboni, C. Vitale, P. Barone, M.T. Pellecchia (Baronissi, Italy)

    Objective: To explore the relationships between nigrostriatal dysfunction and both neuropsychiatric (including anxiety, depression and apathy) and cognitive symptoms in newly diagnosed, drug-naive Parkinson's disease…
  • 2016 International Congress

    Neuropsychological safety of bilateral pallidal (GPi) deep brain stimulation (DBS) for Parkinson’s disease (PD) under general anesthesia

    A.I. Tröster, F.A. Ponce, L. Autry, M. Lambert, V.G. Evidente, S. Oravivattanakul, A. Lieberman, G. Moguel-Cobos, N. Salins, K. Hanson (Phoenix, AZ, USA)

    Objective: To evaluate neuropsychological outcome of bilateral GPi DBS carried out under general anesthesia using a combination of direct anatomical targeting and intraoperative computed tomography…
  • 2016 International Congress

    Screening for neuropsychiatric symptoms in Parkinson’s disease

    M.J. Barrett, S.A. Sperling, B.B. Shah, J.L. Flanigan, G.F. Wooten, M.B. Harrison, C.A. Manning (Charlottesville, VA, USA)

    Objective: To determine the convergent validity of the screening questions included in instructions to patients for Part 1A of the International Parkinson and Movement Disorder…
  • 2016 International Congress

    Suggested protocol for electroconvulsive therapy for depression in a Parkinson’s disease patient with a deep brain stimulator: A case report

    K. Dashtipour, M. Pereau, D. Trenkle, C. Osorio, K. Stoletniy (Loma Linda, CA, USA)

    Objective: To report an evidence for safety of ECT in patients with DBS in place. Background: We report a case of bilateral electroconvulsive therapy (ECT)…
  • 2016 International Congress

    Anxiety and parkinsonism signs in idiopathic REM sleep behavior disorder

    F. Escudier, R.B. Postuma, P.A. Bourgouin, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)

    Objective: To explore the relationship between parkinsonism signs and anxiety symptoms in patients with idiopathic REM sleep behavior disorder (iRBD). Background: A recent study reported…
  • 2016 International Congress

    Cognitive impairment in Parkinson’s disease

    B. Kurbanov (Tashkent, Uzbekistan)

    Objective: To study features of cognitive symptoms in PD, depending on the severity of the disease. Background: Parkinson's disease (PD) is shown a wide range…
  • 2016 International Congress

    The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale

    L.S. Croll, K.M. Montgomery, C.V. Kulick, M.J. Nirenberg (New York, NY, USA)

    Objective: To describe the development of the dopamine agonist withdrawal syndrome (DAWS) rating scale (DAWS-RS), a new questionnaire designed to evaluate the symptoms, severity, and…
  • 2016 International Congress

    Cervical dystonia and quality of life

    S. Tomic, I. Petkovic, T. Pucic, S. Juric, S. Butkovic Soldo (Osijek, Croatia)

    Objective: To evaluate appearance of depression and anxiety in patiens with cervical dystonia and influence of dystonia symptoms on the quality of life. Background: Cervical…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley